Kognition

RacetameStudienlage & Dosis

Piracetam, Aniracetam, Oxiracetam — Graubereich-Nootropics, Evidenz schwach.

Studienlage in Zahlen

Studien gesamt: 107
Mit Abstract: 50
Meta / Systematic / RCT: 0
Häufig zitiert: 50
Erscheinungsjahre: 1992–2026

Racetame im Kontext von Kognition

Dieses Thema ist Teil unserer Welt „Kognition". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Kognition

Top-Studien zu Racetame

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

Glutamate as a neurotransmitter in the brain: review of physiology and pathology.
The Journal of nutrition2000200 einflussreiche Zitationen
Glutamate is the principal excitatory neurotransmitter in brain. Our knowledge of the glutamatergic synapse has advanced enormously in the last 10 years, primarily through application of molecular biological techniques to the study of…
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024200 einflussreiche Zitationen
N-methyl-D-aspartate (NMDA) receptors mediate a slow component of excitatory synaptic transmission, are widely distributed throughout the central nervous system, and regulate synaptic plasticity. NMDA receptor modulators have long been…
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
CNS Drugs2022n=3.182review168 einflussreiche Zitationen
The developmental and epileptic encephalopathies encompass a group of rare syndromes characterised by severe drug-resistant epilepsy with onset in childhood and significant neurodevelopmental comorbidities. The latter include intellectual…
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders.
Pharmaceuticals (Basel, Switzerland)2024141 einflussreiche Zitationen
Neurodegenerative disorders (NDs) include a range of chronic conditions characterized by progressive neuronal loss, leading to cognitive, motor, and behavioral impairments. Common examples include Alzheimer's disease (AD) and Parkinson's…
Clinical experience with excitatory amino acid antagonist drugs.
Stroke1995139 einflussreiche Zitationen
<h4>Background</h4>Excitotoxic damage due to excess release of neuronal glutamate is hypothesized to play a pivotal role in the pathogenesis of focal cerebral ischemia. Drugs that antagonize excitatory amino acid function are consistently…
Novel psychoactive substances of interest for psychiatry.
World psychiatry : official journal of the World Psychiatric Association (WPA)2015109 einflussreiche Zitationen
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor…
Glutamate as a therapeutic target in psychiatric disorders.
Molecular psychiatry2004108 einflussreiche Zitationen
Glutamate is the primary excitatory neurotransmitter in the mammalian brain. Glutamatergic neurotransmission may be modulated at multiple levels, only a minority of which are currently being exploited for pharmaceutical development.…
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.
Trends in pharmacological sciences1993100 einflussreiche Zitationen
NMDA and non-NMDA (AMPA/kainate) antagonists have potential in the treatment of a diverse group of neurological disorders associated with excessive activation of excitatory amino acid receptors. Here Michael Rogawski reviews recent…
Cognitive enhancement as a treatment for drug addictions.
Neuropharmacology2013n=1.16194 einflussreiche Zitationen
Drug addiction continues to be an important public health problem, with an estimated 22.6 million current illicit drug users in the United States alone. For many addictions, including cocaine, methamphetamine, and marijuana addiction,…
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Journal of neural transmission. Supplementum199487 einflussreiche Zitationen
The pharmacological inhibition of excitatory amino acid neurotransmission has evolved to be a major topic in neuropharmacology since enhanced synaptic action of glutamate and possibly other related neurotransmitters has been suggested to…